Studio Investment Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$280K Hold
689
0.06% 155
2025
Q1
$343K Sell
689
-47
-6% -$23.4K 0.07% 140
2024
Q4
$383K Sell
736
-58
-7% -$30.2K 0.08% 124
2024
Q3
$491K Buy
794
+26
+3% +$16.1K 0.1% 112
2024
Q2
$425K Buy
768
+16
+2% +$8.86K 0.1% 111
2024
Q1
$437K Buy
752
+51
+7% +$29.7K 0.1% 113
2023
Q4
$372K Sell
701
-109
-13% -$57.9K 0.09% 116
2023
Q3
$410K Buy
810
+42
+5% +$21.3K 0.11% 98
2023
Q2
$401K Buy
768
+75
+11% +$39.2K 0.11% 101
2023
Q1
$400K Buy
693
+2
+0.3% +$1.15K 0.12% 96
2022
Q4
$381K Buy
691
+35
+5% +$19.3K 0.12% 92
2022
Q3
$333K Buy
656
+4
+0.6% +$2.03K 0.12% 100
2022
Q2
$354K Buy
652
+226
+53% +$123K 0.12% 95
2022
Q1
$252K Buy
426
+18
+4% +$10.6K 0.08% 100
2021
Q4
$272K Buy
408
+44
+12% +$29.3K 0.1% 101
2021
Q3
$208K Buy
+364
New +$208K 0.09% 101